Global Nanotechnology Services Market

Nanotechnology clothing refers to the use of nanoparticles or nanofibers in the production of clothes and fabric, which afterwards enables the enhancement of fabric qualities without noticeably increasing weight, thickness, or stiffness. Nanoparticles are increasingly used along with fibers or as a coating on clothing to enhance the surface characteristics of clothes such as microbicidal, waterproof, antistatic or UV-protection, color durable, dirt-resistant, odor-resistant, stain-resistant, wrinkle-resistant, and better thermal performance. The main types of nanotechnology clothing are nanocoated textiles, nanoporous textiles, fabrics consisting of nanofiber webs, composite fibers based on nanostructures. Nanocoatings are thin films in the nanoscale (about 1–100 nm) that are used to coat surfaces to improve a variety of features, such as antibacterial and anti-fouling capabilities, corrosion resistance, and water/ice protection. Its various application includes healthcare, packaging, sports and leisure, defense, home and household, environmental protection, geotextiles, and others and are used by men, women, and kids. The nanotechnology clothing market research report is one of a series of new reports from The Business Research Company that provides nanotechnology clothing market statistics, including nanotechnology clothing industry global market size, regional shares, competitors with a nanotechnology clothing market share, detailed nanotechnology clothing market segments, market trends and opportunities, and any further data you may need to thrive in the nanotechnology clothing industry. This nanotechnology clothing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global nanotechnology clothing market size will grow from $5.75 billion in 2022 to $7.16 billion in 2023 at a compound annual growth rate (CAGR) of 24.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global nanotechnology clothing market size is expected to grow to $17.22 billion in 2027 at a CAGR of 24.6%. The rising use of nanotechnology clothing in the medical industry, owing to its anti-microbial properties, is expected to drive the nanotechnology clothing market. Nanotechnology clothing offers the anti-microbial property to fight against microorganisms such as viruses, fungi, and bacteria. The companies functioning in the nanotechnology clothing market are introducing medical products to deal with microorganisms. For instance, in March 2021, Anxin, a Zhuhai-based mask manufacturer came up with bacteria-killing reusable nano-silver masks to meet the increasing demand for face masks post-COVID-19 outbreak. The nano-silver particles continuously release irons that are capable of killing bacteria and viruses. Therefore, the growing usage of nanotechnology fibers or clothing in the healthcare industry is projected to boost the revenues for the nanotechnology clothing market over the forthcoming years. The toxicity of nanomaterials is expected to hinder the nanotechnology clothing market’s growth during the forecast period. According to the Indonesian Journal of Electrical Engineering and Computer Science, nanomaterials or nanoparticles are toxic to the human body and can easily enter the circulatory system through skin, lungs, and intestinal organs. The inhalation of nanomaterials leads to the entry of these materials into the human body and then reaches the brain causing damage or death. Thus, the toxicity of nanomaterials is anticipated to hamper the growth of the nanotechnology clothing market during the forecast period. The launch of new products incorporating wearable technology is a key trend shaping the growth of the market. Major players operating in the nanotechnology clothing market are launching a new line of clothing with wearable technology in order to maintain their competitive position in the global market. For instance, in December 2021, NanoTextile, a Malaysia-based nanotechnology firm, launched a new theme called ‘Beneath Hijab’. "Beneath Hijab" was influenced by the underscarf or inners, which are available in a wide variety of patterns, silhouettes, and colours. Beneath Hijab's main goal is to offer comfort behind functionality. The product's incorporated nanotechnology is referred to as having "functionality." This inner scarf nanotechnology is a component of NanoTextile's Hygienic Series of products, which also includes antibacterial, odourless, and self-cleaning technologies. Major players in the nanotechnology clothing market are Nano Textile, Colmar, Shanghai Huzheng Nano Technology, eSpin Technologies, FTEnE, Parker Hannifin, Schoeller Technologies, Odegon Technologies, Aspen Aerogel, and BASF. Western Europe was the largest region in the nanotechnology clothing market in 2022. Asia-Pacific was the second largest region in the global nanotechnology clothing market. The regions covered in the global nanotechnology clothing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the nanotechnology clothing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA. The nanotechnology clothing market consists of sales of nanowhiskers, silver nanoparticles, nanopores, and nanoparticles. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global nanotechnology clothing market is segmented - 1) By Type: Nanocoated Textiles, Nanoporous Textiles, Fabrics Consisting of Nanofiber Webs, Composite Fibres based on Nanostructures 2) By Application: Healthcare, Packaging, Sports and Leisure, Defense, Home and Household, Environmental protection, Geotextiles, Other Applications 3) By End-User Sex: Men, Women, Kids

The scientific research and development services are responsible for conducting original research on a systematic basis to gain new knowledge and to apply research findings or other scientific knowledge to create new or improved products or processes. The main types of scientific research and development services are social sciences and humanities services; physical, engineering, and life sciences; nanotechnology services; and biotechnology services. Nanotechnology is the near-atomic manipulation of matter to create new structures, materials, and technologies. Many fields, including medical, consumer goods, energy, materials, and manufacturing, will benefit from the technology. The different sizes of enterprises include large enterprises, small and medium enterprises, and involve various modes such as online and offline. The scientific research and development services market research report is one of a series of new reports from The Business Research Company that provides scientific research and development services market statistics, including scientific research and development services industry global market size, regional shares, competitors with a scientific research and development services market share, detailed scientific research and development services market segments, market trends and opportunities, and any further data you may need to thrive in the scientific research and development services industry. This scientific research and development services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global scientific research and development services market grew from $817.06 billion in 2022 to $897.68 billion in 2023 at a compound annual growth rate (CAGR) of 9.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, and affecting many markets across the globe. The scientific research and development service market is expected to grow from $1,254.27 billion in 2027 at a CAGR of 8.7%. The scientific research and development services market is expected to grow rapidly due to increasing lifestyle and chronic diseases. This is mainly due to unhealthy lifestyles, a growing ageing population, rising inactivity and obesity. According to the World Health Organization, chronic disease prevalence reached 57% globally in 2020. China and India together had about 193.4 million diabetic patients in 2019, and India is expected to have about 101 million diabetic patients by 2030. In the field of mental health, the World Health Organization predicts that one in every four people will be affected by a type of mental disorder such as depression, schizophrenia, or anxiety in the future. In response to this, national governments across the globe are rapidly increasing their medical research expenditure. For instance, China's medical research spending has increased and will reach $1 trillion in 2020. Therefore, increasing investment in medical research to treat chronic diseases is further driving the demand for scientific research and development services. The outbreak of COVID-19 disease (COVID-19) has acted as a restraint on the scientific research and development services market in 2020 as governments globally imposed lockdowns and restricted trade, thereby limiting the need for professional services. COVID-19 is an infectious disease with flu-like symptoms including fever, cough, and difficulty breathing. The virus was first identified in 2019 in Wuhan, Hubei province of the People’s Republic of China and has spread globally, including Western Europe, North America, and Asia. Steps by national governments to contain the transmission have resulted in a decline in economic activity with countries entering a state of "lock down." The outbreak has had a negative impact on businesses throughout 2020 and into 2021. However, it is expected that the scientific research and development services market will recover from the shock over the forecast period as it is a "black swan" event and not related to ongoing or fundamental weaknesses in the market or the global economy. 4D printing has evolved from 3D printing with the additional feature of changing the geometrical shape and mechanical properties, with time being integrated as an additional fourth dimension. One of the major drawbacks of 3D printing is that it can only take the shape in which it was originally made and is static and inanimate. With the latest development of 4D printing, objects can now be made with responsive materials with certain inherent properties that can change or transform in response to external stimuli. It has widespread applications in medical science, such as tissue regeneration in the biomedical field. For example, printed micro tissue from bio ink can undergo maturation via cellular coating to form functional tissue constructs such as engineered tissue constructs. Major biotechnology research companies using 4D bio printing technology include Poietis, Biolife4D, and Precise Bio. Major companies in the scientific research and development services market include IQVIA Holdings Inc., Battelle Memorial Institute, Defense Advanced Research Projects Agency, Lawrence Livermore National Laboratory LLC, Charles River Laboratories, Inc., Frog Design, Lawrence Berkeley National Lab, Jackson Laboratory, Piramal Group, and WuXi AppTec Co., Ltd. North America was the largest region in the scientific research and development services market in 2022. Asia-Pacific was the second largest region in the scientific research and development services market. The regions covered in the scientific research and development services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the scientific research and development services market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The scientific research and development services market consists of revenue earned by entities that engage in research and experimental development on a contract, consultancy, or outsourced basis. Scientific research and development services establishments undertake processes where human capital is the major input. They make available the knowledge and skills of their employees, often on an assignment basis, where an individual or team is responsible for the delivery of services to the client. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global scientific research and development services market is segmented - 1) By Type: Social Sciences And Humanities Services, Physical, Engineering, And Life Sciences, Nanotechnology Services, Biotechnology Services 2) By End User Size: Large Enterprise, Small and Medium Enterprise 3) By Mode: Online, Offline

Nanosilica refers to an allotrope of silicon containing 99% silicon dioxide, which lowers the cement volume while finishing the grading of the aggregate mix in the zone of the smallest sizes. This is the second most abundant element in the earth’s crust. The nanosilica market covered in this report is segmented by type into P type, S type, and type III. It is also segmented by raw material into rice husk, olivine, bagasse, and others and by application into rubber, health and medicine, food, coatings, plastic, concrete, gypsum, cosmetics, electronics, and others. The nanosilica market research report is one of a series of new reports from The Business Research Company that provides nanosilica market statistics, including nanosilica industry global market size, regional shares, competitors with a nanosilica market share, detailed nanosilica market segments, market trends and opportunities, and any further data you may need to thrive in the nanosilica industry. This nanosilica market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global nanosilica market size grew from $3.95 billion in 2022 to $4.28 billion in 2023 at a compound annual growth rate (CAGR) of 8.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The nanosilica market size is expected to grow to $5.4 billion in 2027 at a CAGR of 6.0%. Increased demand for nanoparticles in the medical industry contributed to the growth of the nano-silica market. Nanoparticles are presently being engaged as a tool to explore the rarest approaches of medical sciences in several ways like imaging, sensing, targeted drug delivery, gene delivery systems, and artificial implants. A replacement study done by Washington University (GW) Cancer Center found that nanoparticle-encapsulated doxorubicin is promising in the treatment of triple-negative carcinoma. Doxorubicin may be a well-known anthracycline drug class used primarily together with chemotherapy. Amino-functionalized silica nanoparticles (SiNPs) are being used as targeted delivery vehicles for the potential treatment of carcinoma. SiNPs can efficiently encapsulate doxorubicin and may be attached to a targeting moiety like anti-Claudin-4 (CLN4). Nanoparticles have been found to help increase the contrast of the image produced by ultrasonography particularly when imaging tumors. The nanoparticles market experiences huge demand from the medical industry, which in turn will propel the revenues generated for the nano-silica market. An increase in the government-sanctioned lockdowns and several manufacturing plants being restricted for an inconsiderable period had impeded the growth of the global nano-silica market. The government shutdown has proved extremely tough for the construction industry which uses nano-silica in its cement-based materials, especially concrete. According to the BLDUP data published in 2020, the government shutdown’s impact on the construction industry was that all the construction projects that were under federal funding ended up losing profits and employee productivity. According to the Congressional Budget Office, the five-week cessation took a meaningful economic toll, costing the USA economy $11 billion, with nearly a quarter of that total invariably lost. Thus, the mass closure of construction industries has negatively affected the growth of the nano-silica market. The launch of 3D printing aerogel microstructures has created immense demand in the nano-silica market. The 3D-printed aerogel micro-structures provide thermal insulation for miniature components. For instance, in 2020, a team of EMPA in Switzerland developed a technique to 3D print microstructures using insulating silica aerogels. The team has clicked in generating stable, well-acclimated microstructures from silica aerogel by utilizing a 3D printer. The printed structures can be as slender as a tenth of a millimetre. The aerogel can be used to insulate small electronic components and even build small pumps and sensors. The thermal conductivity of the silica aerogel is scarcely under 16 mW/(m*K), which is half of that of polystyrene, and even extremely less than that of a non-moving layer of air at 26 mW/(m*K). At an equivalent period of your time, the printed silica aerogel has even more evolved mechanical attributes and may even be riddled and crushed. This exposes completely new feasibilities for the post-processing of 3D-printed aerogel mouldings. U.S. Silica Holdings, Inc., a US-based producer of commercial silica, announced the acquisition of EP Minerals for $750 million. The acquisition is expected to enhance U.S. Silica Holdings, Inc.,’s Oil and Gas businesses. EP Minerals is a US-based producer of Min-u-Sil Ground Silica used in architectural, industrial, traffic paints, and coatings. Major players in the nanosilica market are NanoPore Incorporated, Fuso Chemical, Evonik, Cabot Corporation, DuPont, Akzonobel, Nanostructured and Amorphous Materials (NanoAmor), Wacker Chemie AG, Normet, and NanosilSdn. Asia-Pacific was the largest region in the nanosilica market in 2022. The regions covered in the nanosilica market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the nanosilica market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The nanosilica market consists of sales of solid silica and shaped silica. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global nanosilica market is segmented - 1) By Type: P Type, S Type, Type III 2) By Raw Material: Rice Husk, Olivine, Bagasse, Other raw Materials 3) By Application: Rubber, Health And Medicine, Food, Coatings, Plastic, Concrete, Gypsum, Cosmetics, Electronics, Other Applications

Next-generation sequencing is a sequencing technology that offers ultra-high throughput, scalability, and speed. The technology is used to determine the genetic variation associated with diseases or other biological phenomena. The main products in the next-generation sequencing market are NextSeq systems, MiniSeq systems, NovaSeq systems, iSeq 100 systems, ion PGM Systems, Ion Proton systems, ion GeneStudio S5 systems, PacBio RS II Systems, sequel systems, and others. The MiniSeq system merges load-and-go operation with an intuitive user interface for a fast, easy NGS workflow. The MiniSeq System integrates clonal amplification, sequencing through synthesis, and base calling into a single benchtop instrument, preventing the requirement for additional equipment. The various technologies in next-generation sequencing are sequencing by synthesis, ion semiconductor sequencing, single-molecule real-time sequencing, nanopore sequencing, and other sequencing technologies that are used in diagnostics, drug discovery, and other applications. The next-generation sequencing market research report is one of a series of new reports from The Business Research Company that provides next-generation sequencing market statistics, including next-generation sequencing industry global market size, regional shares, competitors with a next-generation sequencing market share, detailed next-generation sequencing market segments, market trends and opportunities, and any further data you may need to thrive in the next-generation sequencing industry. This next-generation sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global next generation sequencing market size will grow from $9.22 billion in 2022 to $10.44 billion in 2023 at a compound annual growth rate (CAGR) of 13.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global next generation sequencing market size is expected to grow to $17.32 billion in 2027 at a CAGR of 13.5%. The growing number of cases with chronic conditions such as cancer, AIDS, and thalassemia contributed to the growth of the next-generation sequencing market. Chronic illnesses and disorders are on the rise around the world, an aging population and shifts in social behavior lead to a gradual increase in these widespread and expensive long-term medical issues. Next-generation sequencing (NGS) is a versatile development tool utilized by researchers and clinicians across various cancer studies to recognize biomarkers that give guidance on treatments. The prevalence of chronic diseases is also expected to increase significantly, according to the World Health Organization. Hence, the increase in the number of chronic disease cases will increase the requirement for NGS sequencing and boosts revenues for the next-generation sequencing market. The high cost associated with next-generation sequencing technologies is a key factor hampering the growth of the next-generation sequencing market. The next-generation sequencing market is facing challenges as many people find it difficult to afford the test due to the high cost. Consumables used for sequencing are the costliest portion of testing (68–72% of total cost) as machinery prices are higher in instances of rare disease. According to a review published on economic evaluations of exome and genome sequencing, the cost of next-generation genome sequencing ranges from $1906 to $24,810 for a single test. Therefore, the high cost of next-generation sequencing is anticipated to restrict market growth over the forecast period. Technological advances are shaping the next-generation sequencing market. Major companies operating in the sequencing industry are focusing on developing technologically advanced solutions for next-generation sequencing. For instance, in 2020, Thermo Fisher Scientific introduced hematology-oncology assays for the Ion Torrent Genexus System, which authorize simultaneous analysis of DNA mutations and RNA fusion transcripts in myeloid samples in a single day and also enabled further in which turnaround times for next-generation sequencing (NGS) results could be reduced to less than 24 hours. It also offers researchers the ability to profile 40 DNA targets and 29 fusion driver genes, authorizing observing more than 600 fusion isotypes to recognize biomarkers associated with myeloproliferative neoplasm, acute myeloid leukemia. Major players in the next-generation sequencing market are Illumina Inc., Thermo Fisher Scientific Inc., BGI Group, Agilent Technologies Inc., Qiagen N.V., Hoffmann-La Roche AG, Eurofins Scientific, Oxford Nanopore Technologies, Pacific Biosciences, and 10x Genomics. North America was the largest region in the next-generation sequencing market in 2022. Asia-Pacific was the second largest region in the global next-generation sequencing market. The regions covered in the global next-generation sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the next-generation sequencing market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The next-generation sequencing market consits of sales of genetic sequencing equipment with advanced features and technologies such as ion semiconductor sequencing, nano-pore sequencing, single-molecule real-time sequencing, and other technologies that are used for next generation sequencing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global next generation sequencing market is segmented - 1) By Product: NextSeq Systems, MiniSeq Systems, NovaSeq Systems, iSeq 100 Systems, Ion PGM Systems, Ion Proton Systems, Ion GeneStudio S5 Systems, PacBio RS II Systems, Sequel Systems, Other Products 2) By Technology: Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing, Other Sequencing Technologies 3) By Application: Diagnostics, Drug Discovery, Other Applications

Nano drones refer to extremely small drones or remote-controlled aircraft. They are built with smaller-sized rotors and motors and hence are light in weight, small in size, portable, and easier to control and navigate. The main types of nano drones are fixed-wing nano drones, rotor nano drones, flapping-wing nano drones, and others. Fixed-wing nano drones are used for ISR missions, surveying and mapping, search and rescue, and other aerial applications. The different payloads of nano drones include cameras, control systems, tracking systems, others and are used by various end-users, such as consumers, military or law enforcement, and others. The nano drones market research report is one of a series of new reports from The Business Research Company that provides nano drones market statistics, including nano drones industry global market size, regional shares, competitors with a nano drones market share, detailed nano drones market segments, market trends and opportunities, and any further data you may need to thrive in the nano drones industry. This nano drone market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global nano drones market size grew from $1.3 billion in 2022 to $1.7 billion in 2023 at a compound annual growth rate (CAGR) of 31.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The nano drones market size is expected to grow to $4.81 billion in 2027 at a CAGR of 29.7%. The increase in the adoption of nano-drones by military bodies is contributing to the growth of the nano-drones market. Nano drones are being employed as a major military asset due to their ability to integrate a lot of capabilities into a small form factor. For instance, in May 2020, FLIR Systems, Inc., a US-based company that specializes in the design and production of thermal imaging cameras and sensors, declared that it has been granted an extra $20.6 million deal from the USA Army to deliver its FLIR Black Hornet Nano-UAV Systems. Furthermore, in December 2020, the British army has purchased 30 nano bug drones to allow soldiers to spy on targets up to 2 kilometers (1.25 miles) away, marking the latest move in the contentious use of unmanned aerial vehicles by the military (UAVs). The growing technological advancements are shaping the nano-drones market. In recent years, nano-drone technology has advanced intensely, allowing them to fly faster and deeper than ever before, as well as carry out complex surveillance missions. For instance, in December 2020, BAE Systems, a UK-based aerospace company in collaboration with UAVTEK, a UK-based drone manufacturer developed a super lightweight bug drone based on nanotechnology. The bug is a nano-unmanned aerial vehicle (UAV) that weighs 196g, about the same as a smartphone, has a 40-minute battery life, and a range of 2 kilometers. During a recent Army Warfighting Experiment (AWE) program conducted by the Ministry of Defence's Future Capability Unit, it was the only nano-UAV capable of surviving the harsh weather. In April 2021, Anduril Industries, a US-based defense tech company acquired Area-I for an undisclosed amount. The acquisition enables Anduril to add hardware capabilities of Area-I to its automation and data-sensing technology. Area-I is a US-based small drone company. Major players in the nano drones market are AeroVironment Inc., Aerix Drone, Extreme Fliers, Drona Aviation Pvt Ltd., Guangdong Cheerson Hobby Technology Co. Ltd., Mota Group Inc., Parrot SA, Prox Dynamics, Skyrocket Toys LLC, Horizon Hobby, Lockheed Martin, Israel Aerospace Industries, Elbit Systems, Dajiang Innovation Technology Co., BAE Systems, The Boeing Company, Thales Group, and Textron. North America was the largest region in the nano drones market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nano drones report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the nano drones market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The nano drones market consists of sales of mini drones for smaller operations. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global nano drones market is segmented - 1) By Type: Fixed Wing Nano Drones, Rotor Nano Drones, Flapping Wing Nano Drones, Others 2) By Payload: Camera, Control Systems, Tracking Systems, Others 3) By End User: Consumer, Military Or Law Enforcement, Others

Nanomedicine refers to the use of nanotechnology in medicine. It is described as substances with a size between 1 and 100 nanometers that, in the end, should be able to precisely target tumour cells or important immune cells. Nanomedicine is an important instrument that enables personalized, targeted, and regenerative medicine by delivering improved new drugs, treatments, and implantable devices to clinicians and patients. The main types of nanomedicine are nanoparticles, nanoshells, nanotubes, nanodevices, and others. Nanoparticles are a type of ultrafine particles usually between 1 and 100 nanometers in diameter used in making medicine and drugs. The different forms of modality include diagnostics, treatments and are used in clinical oncology, infectious diseases, clinical cardiology, orthopedics, others. The nanomedicine market research report is one of a series of new reports from The Business Research Company that provides nanomedicine market statistics, including nanomedicine industry global market size, regional shares, competitors with a nanomedicine market share, detailed nanomedicine market segments, market trends and opportunities, and any further data you may need to thrive in the nanomedicine industry. This nanomedicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global nanomedicine market size grew from $253.34 billion in 2022 to $287.42 billion in 2023 at a compound annual growth rate (CAGR) of 13.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The nanomedicine market size is expected to grow to $487.69 billion in 2027 at a CAGR of 14.1%. The rising burden of complex and chronic diseases across the globe is expected to contribute to the growth of the nanomedicine market in the forecast period. Nanomedicine is increasingly being used in treating chronic diseases including cardiovascular disorders, diabetes, cancer, dementia, and others where it helps in the fast metabolism of drugs in the body. According to the international federation of Alzheimer's associations, Alzheimer's Disease International, more than 50 million people are suffering from dementia globally, and is projected to double every 20 years, which will reach 80 million by 2030 and 152 million by 2050. In 2020, the total cancer burden in the world increased to 19.3 million new cases and is predicted to rise to 28.4 million new cancer cases in 2040. This increasing burden of chronic diseases is expected to propel the demand for effective therapeutics treatment based on nanomedicine, thus driving the market. The 4D Nanomedicine is a key trend gaining popularity in the nanomedicine market. 4D nanomedicine is used in medical procedures for safer treatment with nanoparticles. 4D nanomedicine is made with biodegradable and biocompatible nanoalloys that do not accumulate in the body, thus, limiting the side effects. The 4D nanomedicine is accepted as a fundamental development in the treatment and diagnosis of cancer. For instance, in 2020, a research team from The Department of Chemical Sciences, University of Padua investigated and confirmed the effectiveness of inorganic 4D nanoparticles in the biomedical field. 4D nanomedicine offers several advantages to the biomedical field including reduced side effects in a living organism, minimal environmental impact, improved quality of care, and spontaneous effect. In August 2021, Sanofi S.A., a France-based pharmaceutical and healthcare company, acquired Translate Bio, Inc., for $3.2 billion. Under this acquisition, Sanofi accelerates the creation of currently approved Sanofi vaccination programs and opens up the possibility of investigating additional therapeutic fields. The mRNA Center of Excellence at Sanofi is being established more quickly. Full integration strengthens US talent in a promising new technology and improves drug formulation capabilities. Exploring the potential of this technology to create both best-in-class vaccines and treatments is further advanced by Translate Bio's addition of an mRNA technology platform and strong skills to our research. Translate Bio, Inc., is a US-based clinical stage biopharmaceutical company developing a new class of potentially game-changing drugs to treat conditions brought on by protein or gene malfunction or to stop infectious diseases by boosting immune defences. Major players in the nanomedicine market are Pfizer Inc., Nanotherapeutics Inc., NanoViricides Inc., Arrowhead Research Inc., Celgene Corporation, Bio-Gate AG, Merck AG, Ablynx NV, F. Hoffmann-La Roche AG, Nanospectra Biosciences, GE Healthcare, Gilead Sciences Inc., Novartis AG, Amgen Inc., and Sanofi. North America was the largest region in the nanomedicine market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nanomedicine report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the nanomedicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The nanomedicine market consists of sales of gold, silica, iron oxide, polymeric, liposomes, and micelles. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global nanomedicine market is segmented - 1) By Type: Nanoparticles, Nanoshells, Nanotubes, Nanodevices, Other Types 2) By Modality: Diagnostics, Treatments 3) By Application: Clinical Oncology, Infectious Diseases, Clinical Cardiology, Orthopedics, Other Applications

Nanomaterials refer to a type of material having internal structures of 100 nm or less or at least one exterior dimension that is 100 nm or less, and based on research, they use improvements in materials metrology and synthesis gained in favour of microfabrication studies to offer a materials science-based perspective on nanotechnology. The main material type of nanomaterials is carbon-based nanomaterials, metal & non-metal Oxides, metal-based nanomaterials, dendrimers nanomaterials, nano clay, nanocellulose, and others. The carbon-based nanomaterials are made of carbon nanotubes, graphene, and fullerenes. Carbon-based nanomaterials are used in biomedical fields such as biosensors, cancer therapy, tissue engineering, and delivery of therapeutics. The different types of structures include non-polymer organic nanomaterials, and polymeric nanomaterials and are used by various sectors such as paints and coatings, adhesives and sealants, health care and life science, energy, electronics, consumer goods, personal care, and other users. The nanomaterials market research report is one of a series of new reports from The Business Research Company that provides nanomaterials market statistics, including nanomaterials industry global market size, regional shares, competitors with a nanomaterials market share, detailed nanomaterials market segments, market trends and opportunities, and any further data you may need to thrive in the nanomaterials industry. This nanomaterials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global nanomaterials market size grew from $12.68 billion in 2022 to $14.65 billion in 2023 at a compound annual growth rate (CAGR) of 15.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The nanomaterials market size is expected to grow to $26.91 billion in 2027 at a CAGR of 16.4%. The increase in the usage of nanomaterials in the healthcare industry across the globe is contributing to the growth of the nanomaterials market. Nanomaterials are employed in the healthcare industry to target abnormalities in individual cells and even sub-cells and to boost the action of vaccinations and medicines by easily accessing the body. Hence, the demand for nanomaterials is rising with the increase in the application of nanomaterials in healthcare. For instance, according to the Press Trust of India (PTI), an India-based press company report published in 2021, worldwide, there are around 400 major nanotech companies of which, half of the companies are nanomedicine related. In addition, out of the total 30 to 40 major nanotech companies in India, half are related to healthcare. Therefore, the growing presence and usage of nanomaterials in the healthcare industry are expected to fuel the growth of the nanomaterials market over the forthcoming years. Product innovations are shaping the nanomaterials market. Major companies operating in the nanomaterials sector are focused on new product innovations to meet customers' demands and increase their market share. For instance, in 2020, Carnegie Mellon University launched a biosensing platform based on advanced nanomaterials. This biosensing platform identifies SARS-CoV-2 antibodies in a few seconds, a virus responsible for the COVID-19 pandemic. Not only testing but also the platform calculates the patient immunological response to the new vaccines. The biosensing platform based on advanced nanomaterials can also be used for the detection of other infectious diseases. In April 2020, Cabot Corporation, a US-based global specialty performance materials, and chemicals company acquired Shenzhen Sanshun Nano New Materials Co., Ltd (SUSN) for a $115 million deal amount. Through this acquisition, Cabot's market position and formulation skills in the high-growth batteries sector, especially in China, the world's strongest and quickest expanding electric vehicle market, have been greatly strengthened. Shenzhen Sanshun Nano New Materials Co., Ltd (SUSN) is a China-based company that manufactures carbon nanotubes (CNTs) and dispersions. Major players in the nanomaterials market are BASF SE, Bayer AG, Chasm Technologies Ltd., Cnano Technology, DuPont Air Products Nanomaterials LLC, Elmarco Ltd., Finetex ENE, Glonatech SA, Kuraray, Nanocyl SA, NanoViricides Inc., Sumitomo Corporation, Showa Denko, Zyvex Technologies, US Research Nanomaterials Inc., Nanocomposix Inc., Frontier Carbon Corporation, Nanoshel LLC, SkySpring Nanomaterials Inc., Cytodiagnostics Inc., Strem Chemicals Inc., and American Elements. North America was the largest region in the nanomaterials market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nanomaterials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the nanomaterials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The nanomaterials market consists of sales of inorganic-based nanomaterials, organic-based nanomaterials, nanofibers, and composite-based nanomaterials. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global nanomaterials market is segmented - 1) By Material Type: Carbon Based Nanomaterials, Metal And Non-Metal Oxides, Metal Based Nanomaterials, Dendrimers Nanomaterials, Nanoclay, Nanocellulose, Other Materials 2) By Structure Type: Non-Polymer Organic Nanomaterials, Polymeric Nanomaterials 3) By End User: Paint And Coatings, Packaging, Construction, Electronics And Consumer Goods, Other End-Users

Healthcare nanotechnology refers to the area of science that combines nanotechnology with drugs or diagnostic molecules to improve the performance of specific cells or tissues. These materials are produced on a nanoscale level and are safe to inject into the body. Nanotechnologies can greatly enhance medical diagnostics by making them more affordable and practical. The main types of healthcare nanotechnology include organic, inorganic, and carbon-based. Healthcare nanotechnology is used for various diseases such as cardiovascular, oncological, neurological, orthopedic, and infectious diseases. The main applications of healthcare nanotechnology include drug delivery, biomaterials, active implants, and tissue regeneration. The healthcare nanotechnology market research report is one of a series of new reports from The Business Research Company that provides healthcare nanotechnology market statistics, including healthcare nanotechnology industry global market size, regional shares, competitors with healthcare nanotechnology market share, detailed healthcare nanotechnology market segments, market trends and opportunities, and any further data you may need to thrive in the healthcare nanotechnology industry. This healthcare nanotechnology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global healthcare nanotechnology market size grew from $276.91 billion in 2022 to $316.3 billion in 2023 at a compound annual growth rate (CAGR) of 14.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The healthcare nanotechnology market size is expected to grow to $556.04 billion in 2027 at a CAGR of 15.1%. Increasing cancer disease cases are expected to propel the growth of the healthcare nanotechnology market. Nanotechnology is a promising mode of cancer treatment. This improving field of medical research can be used to discover better-personalized treatments for many diseases, including cancer. Globally, the prevalence of cancer is increasing. For instance, according to Globocan, in 2020, global cancer cases increased to 19.3 million cases and 10 million cancer deaths. Therefore, the increasing cancer disease cases are driving the growth of the healthcare nanotechnology market. Strategic collaboration between companies is a key trend gaining popularity in the healthcare nanotechnology market. Companies involved in healthcare nanotechnologies are undergoing partnerships and collaboration to develop new technologies and products. For instance, in July 2020, Nanowear, a US-based developer of a nanosensor technology for medical conditions and chronic disease, announced a partnership with Hackensack Meridian Health Systems. Their aim is to monitor confirmed or suspected COVID-19 patients with Nanowear’s cloth-based nanosensors, which can detect physiological and biomarker changes. Hackensack Meridian Health Systems is a US-based health care chain specializing in academic centers, acute care facilities, and research hospitals. In October 2020, Johnson & Johnson, a US-based healthcare company that develops and manufactures various pharma products, announced the acquisition of Momenta Pharmaceuticals for $6.5 billion. With this acquisition, Johnson & Johnson aims to further advance patient care in autoantibody-driven diseases. Momenta Pharmaceuticals is a UK-based company involved in biotechnology with an innovative scientific platform focused on discovering and developing novel biologic therapeutics. North America was the largest region in the healthcare nanotechnology market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the healthcare nanotechnology report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the Healthcare Nanotechnology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The healthcare nanotechnology market includes revenues earned by entities by targeting tumors, in drug delivery systems, and improving medical imaging. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global healthcare nanotechnology market is segmented - 1) By Disease: Cardiovascular Diseases, Oncological Diseases, Neurological Diseases, Orthopedic Diseases, Infectious Diseases 2) By Type: Organic, Inorganic, Carbon-Based 3) By Application: Drug Delivery, Biomaterials, Active Implants, Tissue Regeneration